Aspocid 75 mg 30 chewable tablets

Aspocid 75 mg 30 chewable tablets

Composition:

Acetylsalicylic acid - 75 mg.
Excipients: mannitol, dextrose (glucose).

Product Description:

Salicylate non-steroidal anti-inflammatory drug (NSAID) with a blood-thinning effect, preventing platelets from sticking together.

Indications for use:

• Secondary prevention of myocardial infarction.
• Prevention of cardiovascular morbidity in patients with stable angina.
• Unstable angina (except for the acute phase).
• Prevention after coronary artery bypass graft and coronary angioplasty (except for the acute phase).
• Secondary prevention of transient ischemic attacks and ischemic cerebrovascular events in the absence of intracerebral hemorrhage.
• The drug is not intended for emergency situations and is limited to chronic diseases.

Method of administration and dosage:

• For oral administration: the tablet should be thoroughly chewed and washed down with a sufficient amount of liquid.
• For adults, the recommended doses are: for secondary prevention of myocardial infarction — 75–160 mg once a day;
• For stable angina — 75–160 mg once a day;
• For unstable angina (outside the acute phase) — 75–100 mg once a day;
• After coronary artery bypass graft — 75–160 mg once a day;
• During coronary angioplasty (outside the acute phase) — 75–160 mg once a day;
• For secondary prevention of transient ischemic attacks and ischemic cerebrovascular events (without intracerebral hemorrhage) — 75–325 mg once a day.
• Treatment is subject to regular review by the attending physician. Contraindications: Children under 12 years of age, and the packaging also indicates a restriction up to 16 years of age without a special medical prescription.
• Hypersensitivity to salicylates, aspirin, and other NSAIDs.
• Tendency to bleeding.
• Peptic ulcer of the stomach and duodenum.
• Severe diseases of the heart, liver, and kidneys.
• Pregnancy and lactation period.

Precautions:

• Use during the last trimester of pregnancy may prolong labor and increase premature bleeding.
• Caution and strict medical supervision are required when prescribing to patients with cardiovascular system diseases and gastrointestinal tract diseases (especially elderly people).
• Alcohol consumption is prohibited during treatment. Side effects: Headache.
• Dizziness.
• Confusion.
• Hearing impairment.
• Tinnitus.
• Gastrointestinal disorders (nausea, heartburn, vomiting, abdominal pain, diarrhea).
• Gastric microbleedings.
• Renal dysfunction and acute renal failure.

Pregnancy and lactation:

Contraindicated during pregnancy and breastfeeding.
Use in the last trimester requires special caution due to the risk of bleeding and impact on labor activity.

Storage conditions:

Store at a temperature not exceeding 30°C in a place inaccessible to children.

Packaging:

Cardboard box contains 30 chewable tablets.